• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glomerular Hypertrophy and Initial Dip in Estimated Glomerular Filtration Rate Following Dapagliflozin Administration.

作者信息

Shimizu Akihiro, Tsuboi Nobuo, Sasaki Takaya, Haruhara Kotaro, Matsumoto Kei, Ueda Hiroyuki, Yokote Shinya, Okabe Masahiro, Hatanaka Saeko, Ikeda Masato, Yokoo Takashi

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.

Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

出版信息

Kidney Int Rep. 2024 Apr 27;9(7):2282-2285. doi: 10.1016/j.ekir.2024.04.046. eCollection 2024 Jul.

DOI:10.1016/j.ekir.2024.04.046
PMID:39081734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11284355/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e267/11284355/7c5965ae4d18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e267/11284355/7c5965ae4d18/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e267/11284355/7c5965ae4d18/gr1.jpg

相似文献

1
Glomerular Hypertrophy and Initial Dip in Estimated Glomerular Filtration Rate Following Dapagliflozin Administration.达格列净给药后肾小球肥大及估算肾小球滤过率的初始下降
Kidney Int Rep. 2024 Apr 27;9(7):2282-2285. doi: 10.1016/j.ekir.2024.04.046. eCollection 2024 Jul.
2
Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus.达格列净对无糖尿病的慢性肾脏病患者初始估算肾小球滤过率下降的影响。
Clin Exp Nephrol. 2023 Jan;27(1):44-53. doi: 10.1007/s10157-022-02277-y. Epub 2022 Sep 17.
3
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF.达格列净起始治疗心力衰竭伴射血分数降低患者后估算肾小球滤过率的初始下降（降低）：来自 DAPA-HF 的观察。
Circulation. 2022 Aug 9;146(6):438-449. doi: 10.1161/CIRCULATIONAHA.121.058910. Epub 2022 Apr 20.
4
Favorable changes in the eGFR slope after dapagliflozin treatment and its association with the initial dip.达格列净治疗后估算肾小球滤过率（eGFR）斜率的有利变化及其与初始下降的关联。
Clin Exp Nephrol. 2024 Dec;28(12):1282-1289. doi: 10.1007/s10157-024-02532-4. Epub 2024 Jul 6.
5
Correction to: Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus.对《达格列净对无糖尿病慢性肾病患者初始估计肾小球滤过率下降的影响》一文的更正
Clin Exp Nephrol. 2023 Jan;27(1):54. doi: 10.1007/s10157-022-02286-x.
6
Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium-Glucose Cotransporter-2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes.钠-葡萄糖共转运蛋白 2 抑制剂起始后估算肾小球滤过率下降对心血管和肾脏结局的临床意义。
J Am Heart Assoc. 2021 Jun;10(11):e020237. doi: 10.1161/JAHA.120.020237. Epub 2021 May 20.
7
Compensatory Structural and Functional Adaptation after Radical Nephrectomy for Renal Cell Carcinoma According to Preoperative Stage of Chronic Kidney Disease.根据慢性肾脏病术前分期，肾细胞癌根治性肾切除术后的代偿性结构和功能适应
J Urol. 2015 Oct;194(4):910-5. doi: 10.1016/j.juro.2015.04.093. Epub 2015 Apr 28.
8
Compensatory structural and functional adaptation after radical nephrectomy for renal cell carcinoma according to preoperative stage of chronic kidney disease. Choi DK, Jung SB, Park BH, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.J Urol. 2015 Oct;194(4):910-5. [Epub 2015 Apr 28]. doi: 10.1016/j.juro.2015.04.093.根据慢性肾病术前分期行根治性肾切除术后肾细胞癌的代偿性结构和功能适应。崔DK，郑SB，朴BH，郑BC，徐SI，全SS，李HM，崔HY，全HG。《泌尿外科杂志》。2015年10月；194(4):910 - 915。[2015年4月28日在线出版]。doi:10.1016/j.juro.2015.04.093
Urol Oncol. 2017 Mar;35(3):118-119. doi: 10.1016/j.urolonc.2016.12.024. Epub 2017 Feb 1.
9
Dapagliflozin and the initial glomerular filtration rate decline in advanced-stage non-diabetic chronic kidney disease.达格列净与晚期非糖尿病慢性肾脏病患者初始肾小球滤过率下降
Clin Exp Nephrol. 2022 Dec;26(12):1242-1243. doi: 10.1007/s10157-022-02260-7. Epub 2022 Aug 1.
10
The relationship of peritubular capillary density with glomerular volume and kidney function in living kidney donors.活体供肾者肾小球体积和肾功能与肾小管周毛细血管密度的关系。
J Nephrol. 2023 Sep;36(7):2111-2124. doi: 10.1007/s40620-023-01734-5. Epub 2023 Sep 28.

引用本文的文献

1
Initial change in fractional excretion of total protein after SGLT2 inhibitors predicts renal prognosis in patients with chronic kidney disease.钠-葡萄糖协同转运蛋白2抑制剂治疗后总蛋白排泄分数的初始变化可预测慢性肾脏病患者的肾脏预后。
Clin Kidney J. 2025 Jul 7;18(8):sfaf209. doi: 10.1093/ckj/sfaf209. eCollection 2025 Aug.
2
Pretreatment GFR Slopes Predict Dapagliflozin Response in IgA Nephropathy.治疗前肾小球滤过率斜率可预测达格列净在IgA肾病中的疗效。
Kidney Int Rep. 2025 Apr 30;10(7):2405-2413. doi: 10.1016/j.ekir.2025.04.042. eCollection 2025 Jul.

本文引用的文献

1
Empagliflozin in Patients with Chronic Kidney Disease.恩格列净在慢性肾脏病患者中的应用。
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
2
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD.在慢性肾脏病患者中，SGLT2 抑制剂达格列净对 eGFR 急性变化的相关性及其后果。
J Am Soc Nephrol. 2022 Nov;33(11):2094-2107. doi: 10.1681/ASN.2022030306. Epub 2022 Aug 17.
3
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
4
Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.大肾单位体积和肾硬化预测肿瘤根治性肾切除术后 CKD 进展和死亡率，与肾功能无关。
J Am Soc Nephrol. 2020 Nov;31(11):2642-2652. doi: 10.1681/ASN.2020040449. Epub 2020 Sep 16.
5
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
6
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.恩格列净与 2 型糖尿病患者的肾脏疾病进展。
N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920. Epub 2016 Jun 14.
7
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.1 型糖尿病患者钠-葡萄糖共转运蛋白 2 抑制剂的肾脏血流动力学效应。
Circulation. 2014 Feb 4;129(5):587-97. doi: 10.1161/CIRCULATIONAHA.113.005081. Epub 2013 Dec 13.
8
Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat.SGLT2 抑制剂对早期糖尿病大鼠肾小球和肾小管功能的急性和慢性影响。
Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R75-83. doi: 10.1152/ajpregu.00357.2011. Epub 2011 Sep 21.
9
Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy.最大肾小球直径作为 IgA 肾病 10 年预后指标。
Nephrol Dial Transplant. 2011 Dec;26(12):3937-43. doi: 10.1093/ndt/gfr139. Epub 2011 Mar 22.